These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22074630

  • 1. Cellular-based therapies to prevent or reduce thrombocytopenia.
    Pineault N, Boyer L.
    Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
    [Abstract] [Full Text] [Related]

  • 2. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO, Danet-Desnoyers GA, Zhang Y, Frank DM, Riley JL, Levine BL, Porter DL, June CH, Emerson SG.
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [Abstract] [Full Text] [Related]

  • 3. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y, Sun A, Han ZC.
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [Abstract] [Full Text] [Related]

  • 4. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ, Shpall EJ, McNiece I, Keller G.
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [Abstract] [Full Text] [Related]

  • 5. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH, Huang SL, Huang K, Wu YF, Bao R, Wei J, Zhang XC, Li Y.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [Abstract] [Full Text] [Related]

  • 6. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [Abstract] [Full Text] [Related]

  • 7. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R, Fibbe WE.
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [Abstract] [Full Text] [Related]

  • 8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [Abstract] [Full Text] [Related]

  • 9. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
    Suzuki K, Hiramatsu H, Fukushima-Shintani M, Heike T, Nakahata T.
    Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
    [Abstract] [Full Text] [Related]

  • 10. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice.
    Yim YS, Noh YH, Kim DH, Lee MW, Cheuh HW, Lee SH, Yoo KH, Jung HL, Sung KW, Choi SJ, Oh WI, Yang YS, Koo HH.
    Transplant Proc; 2010 Sep; 42(7):2753-8. PubMed ID: 20832581
    [Abstract] [Full Text] [Related]

  • 11. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model.
    Ural SH, Sammel MD, Blakemore KJ.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099
    [Abstract] [Full Text] [Related]

  • 12. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT, Lu SH, Li YH, Yang Z, Xu J, Zheng YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [Abstract] [Full Text] [Related]

  • 13. A sensitive quantitative single-platform flow cytometry protocol to measure human platelets in mouse peripheral blood.
    Schipper LF, van Hensbergen Y, Fibbe WE, Brand A.
    Transfusion; 2007 Dec; 47(12):2305-14. PubMed ID: 17764510
    [Abstract] [Full Text] [Related]

  • 14. A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment.
    Angelopoulou MK, Rinder H, Wang C, Burtness B, Cooper DL, Krause DS.
    Transfusion; 2004 Apr; 44(4):555-66. PubMed ID: 15043572
    [Abstract] [Full Text] [Related]

  • 15. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
    Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, Cuthbert A, Burzenski L, Gott B, Lyons B, Foreman O, Rossini AA, Greiner DL.
    Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [Abstract] [Full Text] [Related]

  • 17. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Stewart FM, Quesenberry PJ.
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
    Navarro-Montero O, Romero-Moya D, Montes R, Ramos-Mejía V, Bueno C, Real PJ, Menendez P.
    Clin Immunol; 2012 Nov; 145(2):89-91. PubMed ID: 22964517
    [No Abstract] [Full Text] [Related]

  • 19. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Nov; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 20. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
    Yang HM, Cho MR, Sung JH, Yang SJ, Nam MH, Roh CR, Kim JM, Shin M, Song SH, Kwon CH, Joh JW, Kim SJ.
    Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.